Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence

References

• Arnsten , J , Demas , P , Farzadegan , H , Grant , R , Gourevitch , M , Chang , C , Buono , D , Eckholdt , H , Howard , A and Schoenbaum , E . 2001 . Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self–report and electronic monitoring . Clinical Infectious Diseases , 33 : 1417 – 1423 .
   PubMed Web of Science ®Google Scholar
• Bangsberg , DR , Hecht , FM , Charlebois , ED , Zolopa , AR , Holodniy , M , Sheiner , L , Bamberger , JD , Chesney , MA and Moss , A . 2000 . Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population . AIDS , 14 : 357 – 366 .
   PubMed Web of Science ®Google Scholar
• Bangsberg, D., Perry, S., Charlebois, E., Clark, R., Zolopa, A. & Moss, A. (2001). Adherence to HAART predicts progression to AIDS. Poster presented at the Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, IL, February 4–8.
   Google Scholar
• Bangsberg, D., Charlebois, E., Grant, R., Holodniy, M., Perry, S., Conroy, K.N., Guzman, D., Zolopa, A. & Moss, A. (2002). Low levels of adherence do not increase risk of HIV drug resistance. Poster presented at the Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, WA, February 24–28, p. 256.
   Google Scholar
• Besch , CL . 1995 . Compliance in clinical trials . AIDS , 9 : 1 – 10 .
   PubMed Web of Science ®Google Scholar
• Bing , EG , Hays , RD , Jacobson , LP , Chen , B , Gange , SJ , Kass , NE , Chmiel , JS and Zucconi , SL . 2000 . Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study . Quality of Life Research , 9 : 55 – 63 .
   PubMed Web of Science ®Google Scholar
• Cahn , P , Vibhagool , A , Schechter , M , Soto-Ramirez , L , Carosi , G , Smaill , F , Jordan , JC , Pharo , CE , Thomas , NE and Steel , HM . 2004 . Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine . Current Medical Research Opinions , 20 (7) : 1115 – 1123 .
   PubMed Web of Science ®Google Scholar
• Chesney , MA . 2000 . Factors affecting adherence to antiretroviral therapy . Clinical Infectious Diseases , 30 (Supplement 2) : S171 – S176 .
   PubMedGoogle Scholar
• Cohen , C , Revicki , DA , Nabulsi , A , Sarocco , PW and Jiang , P . 1998 . A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. Advanced HIV Disease Ritonavir Study Group . AIDS , 12 : 1495 – 1502 .
   PubMed Web of Science ®Google Scholar
• Cramer , JA , Mattson , RH , Prevey , ML , Scheyer , RD and Ouellette , VL . 1989 . How often is medication taken as prescribed? A novel assessment technique . Journal of the American Medical Association , 261 : 3273 – 3277 .
   PubMed Web of Science ®Google Scholar
• Crespo-Fierro , M . 1997 . Compliance/adherence and care management in HIV disease . Journal of the Association of Nurses in AIDS Care , 8 : 43 – 54 .
   PubMedGoogle Scholar
• Cunningham , WE , Shapiro , MF , Hays , RD , Dixon , WJ , Visscher , BR , George , WL , Ettl , MK and Beck , CK . 1998 . Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease . American Journal of Medicine , 104 : 129 – 136 .
   PubMed Web of Science ®Google Scholar
• Fischl , M , Ribaudo , H , Collier , A , Erice , A , Giuliano , M , Dehlinger , M , Eron , J , Saag , M , Hammer , S , Vella , S , Morse , GD , Feinberg , JE and For the Adult AIDS Clinical Trials Group 388 Study Team . 2003 . A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced Human Immunodeficiency Virus disease . Journal of Infectious Diseases , 188 : 625 – 634 .
   PubMed Web of Science ®Google Scholar
• Fletcher, C., Testa, M., Haubrich, R., Brundage, R., Jiang, H., Ickovics, J., Martinez, A., Snyder, S. & Gulick, R. (2003). Relationships among four measures of medication adherence and virologic response in ACTG 359. Poster presented at the 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 10–14.
   Google Scholar
• Franchi , D and Wenzel , RP . 1998 . Measuring health-related quality of life among patients infected with human immunodeficiency virus . Clinical Infectious Diseases , 26 : 20 – 26 .
   PubMed Web of Science ®Google Scholar
• Fumaz , CR , Tuldra , A , Ferrer , MJ , Paredes , R , Bonjoch , A , Jou , T , Negredo , E , Romeu , J , Sirera , G , Tural , C and Clotet , B . 2002 . Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens . Journal of Acquired Immune Deficiency Syndrome , 29 : 244 – 253 .
   PubMed Web of Science ®Google Scholar
• Garcia de Olalla , P , Knobel , H , Carmona , A , Guelar , A , Lopez-Colomes , JL and Cayla , JA . 2002 . Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients . Journal of Acquired Immune Deficiency Syndrome , 30 : 105 – 110 .
   PubMed Web of Science ®Google Scholar
• Gifford , AL , Bormann , JE , Shively , MJ , Wright , BC , Richman , DD and Bozzette , SA . 2000 . Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens . Journal of Acquired Immune Deficiency Syndrome , 23 : 386 – 395 .
   PubMed Web of Science ®Google Scholar
• Han , C , Pulling , CC , Telke , SE and Huppler Hullsiek , K . 2002 . Assessing the utility of five domains in SF-12 Health Status Questionnaire in an AIDS clinical trial . AIDS , 16 : 431 – 439 .
   PubMed Web of Science ®Google Scholar
• Haubrich , RH , Little , SJ , Currier , JS , Forthal , DN , Kemper , CA , Beall , GN , Johnson , D , Dube , MP , Hwang , JY and McCutchan , JA . 1999 . The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group . AIDS , 13 : 1099 – 1107 .
   PubMed Web of Science ®Google Scholar
• Hays , RD , Cunningham , WE , Sherbourne , CD , Wilson , IB , Wu , AW , Cleary , PD , McCaffrey , DF , Fleishman , JA , Crystal , S , Collins , R , Eggan , F , Shapiro , MF and Bozzette , SA . 2000 . Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study . American Journal of Medicine , 108 : 714 – 722 .
   PubMed Web of Science ®Google Scholar
• Hecht, F.M., Colfax, G., Swanson, M. & Chesney, M.A. (1998). Adherence and effectiveness of protease inhibitors in clinical practice. Poster presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, IL.
   Google Scholar
• Hogg , RS , Yip , B , Chan , KJ , Wood , E , Craib , KJ , O'Shaughnessy , MV and Montaner , JS . 2001 . Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy . Journal of the American Medical Association , 286 : 2568 – 2577 .
   PubMed Web of Science ®Google Scholar
• Holzemer , WL , Corless , IB , Nokes , KM , Turner , JG , Brown , MA , Powell-Cope , GM , Inouye , J , Henry , SB , Nicholas , PK and Portillo , CJ . 1999 . Predictors of self-reported adherence in persons living with HIV disease . AIDS Patient Care and STDS , 13 : 185 – 197 .
   PubMed Web of Science ®Google Scholar
• Hurst , NP , Ruta , DA and Kind , P . 1998 . Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis . British Journal of Rheumatology , 37 : 862 – 869 .
   PubMedGoogle Scholar
• Jenkinson , C , Wright , L and Coulter , A . 1994 . Criterion validity and reliability of the SF-36 in a population sample . Quality of Life Research , 3 : 7 – 12 .
   PubMed Web of Science ®Google Scholar
• Knobel , H , Guelar , A , Carmona , A , Espona , M , Gonzalez , A , Lopez-Colomes , JL , Saballs , P , Gimeno , JL and Diez , A . 2001 . Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors . AIDS Patient Care STDS , 15 : 193 – 199 .
   PubMed Web of Science ®Google Scholar
• Kodraliu , G , Mosconi , P , Groth , N , Carmosino , G , Perilli , A , Gianicolo , EA , Rossi , C and Apolone , G . 2001 . Subjective health status assessment: evaluation of the Italian version of the SF-12 health survey. Results from the MiOS project . Journal of Epidemiology and Biostatistics , 6 : 305 – 316 .
   PubMedGoogle Scholar
• Liu , H , Golin , CE , Miller , LG , Hays , RD , Beck , CK , Sanandaji , S , Christian , J , Maldonado , T , Duran , D , Kaplan , AH and Wenger , NS . 2001 . A comparison study of multiple measures of adherence to HIV protease inhibitors . Annals of Internal Medicine , 134 : 968 – 977 .
   PubMed Web of Science ®Google Scholar
• Lorenz , KA , Shapiro , MF , Asch , SM , Bozzette , SA and Hays , RD . 2001 . Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection . Annals of Internal Medicine , 134 : 854 – 860 .
   PubMed Web of Science ®Google Scholar
• MacArthur , RD , Chen , L , Mayers , DL , Besch , CL , Novak , R , Berg-Wolf , M , van den Yurik , T , Peng , G , Schmetter , B , Brizz , B and Abrams , D . 2001 . The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial . Controlled Clinical Trials , 22 : 176 – 190 .
   PubMedGoogle Scholar
• Mannheimer , S , Friedland , G , Matts , J , Child , C and Chesney , M . 2002 . The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials . Clinical Infectious Diseases , 34 : 1115 – 1121 .
   PubMed Web of Science ®Google Scholar
• McHorney , CA , Ware , JE, Jr and Raczek , AE . 1993 . The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs . Medical Care , 31 : 247 – 263 .
   PubMed Web of Science ®Google Scholar
• McHorney , CA , Ware , JE, Jr , Lu , JF and Sherbourne , CD . 1994 . The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups . Medical Care , 32 : 40 – 66 .
   PubMed Web of Science ®Google Scholar
• Mellors, J., Vaida, F., Bennett, K., Hellmann, N.S., Degruttola, V. & Hammer, S., forthe ACTG 398 Study Team (2002). Efavirenz hypersusceptibility improves virologic response to multidrug salvage regimens in ACTG 398. Presented at Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, WA, February 24–28, p. 69.
   Google Scholar
• Montaner , JS , Reiss , P , Cooper , D , Vella , S , Harris , M , Conway , B , Wainberg , MA , Smith , D , Robinson , P , Hall , D , Myers , M and Lange , JM . 1998 . A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. Italy, the Netherlands, Canada and Australia study . Journal of the American Medical Association , 279 : 930 – 937 .
   PubMed Web of Science ®Google Scholar
• Montessori, V., Wood, E., Beer, S.L., Yip, B., O'Shaughnessy, M., Hogg, R. & Montaner, J. (2000). Virologic success rates drop off sharply with decreasing levels of adherence to antiretroviral therapy. Poster presented at the 13th International AIDS Conference, Durban, South Africa.
   Google Scholar
• Nicholas, P.K., Corless, I.B., Davis, S.M., Dolan, S.E. & McGibbon, C.A. (2002). Symptom status and quality of life in HIV disease. Poster presented at the 14th International AIDS Conference, Barcelona, Spain, July 7–12.
   Google Scholar
• Nieuwkerk , PT , Reijers , MH , Weigel , HM , Lange , JM and Sprangers , MA . 2000a . Quality of life in maintenance vs. prolonged induction therapy for HIV . Journal of the American Medical Association , 284 : 178 – 179 .
   PubMed Web of Science ®Google Scholar
• Nieuwkerk , PT , Gisolf , EH , Colebunders , R , Wu , AW , Danner , SA and Sprangers , MA . 2000b . Quality of life in asymptomatic and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group . AIDS , 14 : 181 – 187 .
   PubMed Web of Science ®Google Scholar
• Nieuwkerk , PT , Gisolf , EH , Reijers , MH , Lange , JM , Danner , SA and Sprangers , MA . 2001 . Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection . AIDS , 15 : 1985 – 1991 .
   PubMed Web of Science ®Google Scholar
• Nieuwkerk, P.T., Hillebrand, M.E., Vriesendorp, R., Frissen, P.H.J., De Wolf, F., Lange, J.M.A. & Sprangers, M.A.G. (2002). Effect on patients’ quality of life (QoL) of starting HAART at different CD4 cell counts. Poster presented at the 14th International AIDS Conference, Barcelona, Spain, July 7–12.
   Google Scholar
• Orlando, G., Guaraldi, G., Murri, R., Wu, A., Nardini, G., Beghetto, B., Sterrantino, G.K., Sbaragli, S., Borderi, M., Talo, S., Grosso, C., Erba, C., Cattelan, A.M., Antinori, A. & Esposito, R. (2002). Does lipodystrophy affect quality of life? Poster presented at the 14th International AIDS Conference, Barcelona, Spain, July 7–12.
   Google Scholar
• Paterson , DL , Swindells , S , Mohr , J , Brester , M , Vergis , EN , Squier , C , Wagener , MM and Singh , N . 2000 . Adherence to protease inhibitor therapy and outcomes in patients with HIV infection . Annals of Internal Medicine , 133 : 21 – 30 .
   PubMed Web of Science ®Google Scholar
• Raboud , JM , Harris , M , Rae , S and Montaner , JS . 2002 . Impact of adherence on duration of virological suppression among patients receiving combination antiretroviral therapy . HIV Medicine , 3 : 118 – 124 .
   PubMedGoogle Scholar
• Revicki , DA , Moyle , G , Stellbrink , HJ and Barker , C . 1999a . Quality of life outcomes of combination zalcitabine–zidovudine, saquinavir–zidovudine, and saquinavir–zalcitabine–zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group . AIDS , 13 : 851 – 858 .
   PubMed Web of Science ®Google Scholar
• Revicki , DA , Swartz , C , Wu , AW , Haubrich , R and Collier , AC . 1999b . Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3 . Antiviral Therapy , 4 : 35 – 44 .
   PubMed Web of Science ®Google Scholar
• Samet , JH , Libman , H , Steger , KA , Dhawan , RK , Chen , J , Shevitz , AH , Dewees-Dunk , R , Levenson , S , Kufe , D and Craven , DE . 1992 . Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic . American Journal of Medicine , 92 : 495 – 502 .
   PubMed Web of Science ®Google Scholar
• Singh , N , Squier , C , Sivek , C , Wagener , M , Nguyen , MH and Yu , VL . 1996 . Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance . AIDS Care , 8 : 261 – 269 .
   PubMed Web of Science ®Google Scholar
• Sipes, C.S., Jones, S.G., Kauschinger, E., Brown, B., Johnson, B., Joy, C., Buscemi, C., Rossi, D., Berger, B. & Relf, M. (2002). Tolerability of medication assessment (TOMA) instrument demonstrates correlation between severity of drug side effects, impact on activities of daily living (ADLs), and perceived quality of life (QOL). Poster presented at the 14th International AIDS Conference, Barcelona, Spain, July 7–12.
   Google Scholar
• Swindells , S , Mohr , J , Justis , JC , Berman , S , Squier , C , Wagener , MM and Singh , N . 1999 . Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness . International Journal of STD and AIDS , 10 : 383 – 391 .
   PubMed Web of Science ®Google Scholar
• Vogl , D , Rosenfeld , B , Breitbart , W , Thaler , H , Passik , S , McDonald , M and Portenoy , RK . 1999 . Symptom prevalence, characteristics, and distress in AIDS outpatients . Journal of Pain Symptom Management , 18 : 253 – 262 .
   PubMed Web of Science ®Google Scholar
• Ware , J, Jr , Kosinski , M and Keller , SD . 1996 . A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity . Medical Care , 34 : 220 – 233 .
   PubMed Web of Science ®Google Scholar
• Ware J Kosinski M Keller S SF-12: how to score the SF-12 physical and mental health summary scales, QualityMetric Incorporated Rhode Island 1998
   Google Scholar
• Waterhouse , DM , Calzone , KA , Mele , C and Brenner , DE . 1993 . Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring . Journal of Clinical Oncology , 11 : 1189 – 1197 .
   PubMed Web of Science ®Google Scholar
• Wu , AW . 2000 . Quality of life assessment comes of age in the era of highly active antiretroviral therapy . AIDS , 14 : 1449 – 1451 .
   PubMed Web of Science ®Google Scholar
• Wu , AW , Rubin , HR , Mathews , WC , Ware , JE, Jr , Brysk , LT , Hardy , WD , Bozzette , SA , Spector , SA and Richman , DD . 1991 . A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection . Medical Care , 29 : 786 – 798 .
   PubMed Web of Science ®Google Scholar
• Wu , AW , Hays , RD , Kelly , S , Malitz , F and Bozzette , SA . 1997 . Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS . Quality of Life Research , 6 : 531 – 554 .
   PubMed Web of Science ®Google Scholar
• Zinkernagel , C , Ledergerber , B , Battegay , M , Cone , RW , Vernazza , P , Hirschel , B and Opravil , M . 1999 . Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV cohort study . AIDS , 13 : 1587 – 1589 .
   PubMed Web of Science ®Google Scholar